Department of Pathology, Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, Texas, USA.
Diagn Pathol. 2008 Feb 8;3:6. doi: 10.1186/1746-1596-3-6.
In this article, the authors briefly review the historical evolution of the various putative precursor lesions for Type II endometrial cancers, with an emphasis on the newly defined "Endometrial Glandular Dysplasia (EmGD)". The evidentiary basis for delineating serous EmGD as the most probable precursor lesions to endometrial serous carcinoma is reviewed in detail. An argument is advanced for the discontinuation of the term serous "endometrial intraepithelial carcinoma (EIC)" as a descriptor for a supposedly intraepithelial, precancerous lesion. Preliminary evidence is also presented that suggests that there is a morphologically recognizable "clear cell EmGD" that probably represents a precancerous lesion to endometrial clear cell carcinomas.
本文作者简要回顾了 II 型子宫内膜癌各种假定前体病变的历史演变,重点介绍了新定义的“子宫内膜腺体异型增生(EmGD)”。详细回顾了将浆液性 EmGD 划定为子宫内膜浆液性癌最可能前体病变的证据基础。提出停止使用浆液性“子宫内膜上皮内癌(EIC)”作为一种假定的上皮内癌前病变的术语。初步证据还表明,可能存在一种形态上可识别的“透明细胞 EmGD”,它可能代表子宫内膜透明细胞癌的癌前病变。